Site- and Size-Controlled PEGylation Modulates Biointerfaces and Immunoregulatory Functions of Bifunctional Peptides in an Autoimmune Disease Model. [PDF]
ACS Appl Mater InterfacesSong SJ +5 more
europepmc +1 more source
Use of the MOF NU-1000 as a Drug Delivery System for the Antineoplastic Drug Mitoxantrone. [PDF]
Int J Mol SciAlfonso DR +7 more
europepmc +1 more source
Mechanistic Insights Into the Retention and Separation Mechanism of Poly(Ethylene Glycol)-Modified Short Oligonucleotides in Anion-Exchange Chromatography. [PDF]
Biotechnol JYoshimoto N +3 more
europepmc +1 more source
Inactivation of PETase at Interfaces Inhibits PET Plastic Depolymerization. [PDF]
ACS Sustain Chem EngRobinson A +9 more
europepmc +1 more source
PEGylation Overcomes Pharmacological Barriers to Improve Systemic Pharmacokinetics and Therapeutic Efficacy of Phages against MDR <i>Escherichia coli</i>. [PDF]
J Microbiol BiotechnolShamsuzzaman M +5 more
europepmc +1 more source
mRNA Delivery by Lipoamino Fatty Acid-Peptide Polyplexes in Different Lung Cell Models and Lungs. [PDF]
Polymers (Basel)Thalmayr S +8 more
europepmc +1 more source
PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells. [PDF]
Bioeng Transl MedCahn D +8 more
europepmc +1 more source
Silver nanoparticle-induced site-specific strand cleavage of chemically modified oligonucleotides for long-chain DNA assembly. [PDF]
Nucleic Acids ResInagaki M +7 more
europepmc +1 more source
Integrative Peptide Drug Development: Chemical Engineering, AI-Driven Design, and Cell-Penetrating Peptides. [PDF]
PharmaceuticsJang YE +10 more
europepmc +1 more source
Site-specific PEGylation of proteins: Insights into structural and functional changes. [PDF]
Acta Pharm Sin BMa M +7 more
europepmc +1 more source